175 related articles for article (PubMed ID: 20861259)
1. Vaccinia virus D4 mutants defective in processive DNA synthesis retain binding to A20 and DNA.
Druck Shudofsky AM; Silverman JE; Chattopadhyay D; Ricciardi RP
J Virol; 2010 Dec; 84(23):12325-35. PubMed ID: 20861259
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia virus uracil DNA glycosylase interacts with the A20 protein to form a heterodimeric processivity factor for the viral DNA polymerase.
Stanitsa ES; Arps L; Traktman P
J Biol Chem; 2006 Feb; 281(6):3439-51. PubMed ID: 16326701
[TBL] [Abstract][Full Text] [Related]
3. The vaccinia virus DNA polymerase and its processivity factor.
Czarnecki MW; Traktman P
Virus Res; 2017 Apr; 234():193-206. PubMed ID: 28159613
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of point mutations at the Vaccinia virus A20/D4 interface.
Contesto-Richefeu C; Tarbouriech N; Brazzolotto X; Burmeister WP; Peyrefitte CN; Iseni F
Acta Crystallogr F Struct Biol Commun; 2016 Sep; 72(Pt 9):687-91. PubMed ID: 27599859
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the role of the vaccinia virus uracil DNA glycosylase and A20 proteins as intrinsic components of the DNA polymerase holoenzyme.
Boyle KA; Stanitsa ES; Greseth MD; Lindgren JK; Traktman P
J Biol Chem; 2011 Jul; 286(28):24702-13. PubMed ID: 21572084
[TBL] [Abstract][Full Text] [Related]
6. A Conserved Tripeptide Sequence at the C Terminus of the Poxvirus DNA Processivity Factor D4 Is Essential for Protein Integrity and Function.
Nuth M; Guan H; Ricciardi RP
J Biol Chem; 2016 Dec; 291(53):27087-27097. PubMed ID: 27836975
[TBL] [Abstract][Full Text] [Related]
7. Crystal Structure of the Vaccinia Virus Uracil-DNA Glycosylase in Complex with DNA.
Burmeister WP; Tarbouriech N; Fender P; Contesto-Richefeu C; Peyrefitte CN; Iseni F
J Biol Chem; 2015 Jul; 290(29):17923-17934. PubMed ID: 26045555
[TBL] [Abstract][Full Text] [Related]
8. Binding of undamaged double stranded DNA to vaccinia virus uracil-DNA Glycosylase.
Schormann N; Banerjee S; Ricciardi R; Chattopadhyay D
BMC Struct Biol; 2015 Jun; 15():10. PubMed ID: 26031450
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of vaccinia virus uracil-DNA glycosylase reveals dimeric assembly.
Schormann N; Grigorian A; Samal A; Krishnan R; DeLucas L; Chattopadhyay D
BMC Struct Biol; 2007 Jul; 7():45. PubMed ID: 17605817
[TBL] [Abstract][Full Text] [Related]
10. Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex.
Su MT; Liu IH; Wu CW; Chang SM; Tsai CH; Yang PW; Chuang YC; Lee CP; Chen MR
J Virol; 2014 Aug; 88(16):8883-99. PubMed ID: 24872582
[TBL] [Abstract][Full Text] [Related]
11. Poxvirus uracil-DNA glycosylase-An unusual member of the family I uracil-DNA glycosylases.
Schormann N; Zhukovskaya N; Bedwell G; Nuth M; Gillilan R; Prevelige PE; Ricciardi RP; Banerjee S; Chattopadhyay D
Protein Sci; 2016 Dec; 25(12):2113-2131. PubMed ID: 27684934
[TBL] [Abstract][Full Text] [Related]
12. Solution Structure of the C-terminal Domain of A20, the Missing Brick for the Characterization of the Interface between Vaccinia Virus DNA Polymerase and its Processivity Factor.
Bersch B; Tarbouriech N; Burmeister WP; Iseni F
J Mol Biol; 2021 Jun; 433(13):167009. PubMed ID: 33901538
[TBL] [Abstract][Full Text] [Related]
13. Structure of the uracil complex of Vaccinia virus uracil DNA glycosylase.
Schormann N; Banerjee S; Ricciardi R; Chattopadhyay D
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Dec; 69(Pt 12):1328-34. PubMed ID: 24316823
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the vaccinia virus DNA polymerase holoenzyme subunit D4 in complex with the A20 N-terminal domain.
Contesto-Richefeu C; Tarbouriech N; Brazzolotto X; Betzi S; Morelli X; Burmeister WP; Iseni F
PLoS Pathog; 2014 Mar; 10(3):e1003978. PubMed ID: 24603707
[TBL] [Abstract][Full Text] [Related]
15. Clustered charge-to-alanine mutagenesis of the vaccinia virus A20 gene: temperature-sensitive mutants have a DNA-minus phenotype and are defective in the production of processive DNA polymerase activity.
Punjabi A; Boyle K; DeMasi J; Grubisha O; Unger B; Khanna M; Traktman P
J Virol; 2001 Dec; 75(24):12308-18. PubMed ID: 11711621
[TBL] [Abstract][Full Text] [Related]
16. Crystallization and preliminary X-ray diffraction analysis of three recombinant mutants of Vaccinia virus uracil DNA glycosylase.
Sartmatova D; Nash T; Schormann N; Nuth M; Ricciardi R; Banerjee S; Chattopadhyay D
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Mar; 69(Pt 3):295-301. PubMed ID: 23519808
[TBL] [Abstract][Full Text] [Related]
17. Identification of protein-protein interaction inhibitors targeting vaccinia virus processivity factor for development of antiviral agents.
Schormann N; Sommers CI; Prichard MN; Keith KA; Noah JW; Nuth M; Ricciardi RP; Chattopadhyay D
Antimicrob Agents Chemother; 2011 Nov; 55(11):5054-62. PubMed ID: 21844323
[TBL] [Abstract][Full Text] [Related]
18. Correlated Target Search by Vaccinia Virus Uracil-DNA Glycosylase, a DNA Repair Enzyme and a Processivity Factor of Viral Replication Machinery.
Diatlova EA; Mechetin GV; Yudkina AV; Zharkov VD; Torgasheva NA; Endutkin AV; Shulenina OV; Konevega AL; Gileva IP; Shchelkunov SN; Zharkov DO
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298065
[TBL] [Abstract][Full Text] [Related]
19. Structure and flexibility of the DNA polymerase holoenzyme of vaccinia virus.
Burmeister WP; Boutin L; Balestra AC; Gröger H; Ballandras-Colas A; Hutin S; Kraft C; Grimm C; Böttcher B; Fischer U; Tarbouriech N; Iseni F
PLoS Pathog; 2024 May; 20(5):e1011652. PubMed ID: 38768256
[TBL] [Abstract][Full Text] [Related]
20. Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4.
Nuth M; Huang L; Saw YL; Schormann N; Chattopadhyay D; Ricciardi RP
J Med Chem; 2011 May; 54(9):3260-7. PubMed ID: 21438571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
